Allspring Global Investments
CTKB icon

Allspring Global Investments’s Cytek Biosciences CTKB Stock Holding History

Allspring Global Investments’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-929
Closed -$5.15K – 1925
2024
Q3 		$5.15K Sell
929
-24,215
-96% -$137K ﹤0.01% 2178
2024
Q2 		$140K Buy
+25,144
New +$151K ﹤0.01% 1792
2023
Q4 		– Sell
-4,803
Closed -$26.5K – 2338
2023
Q3 		$26.5K Sell
4,803
-3,096
-39% -$24.8K ﹤0.01% 2445
2023
Q2 		$67.5K Buy
7,899
+1,837
+30% +$16.5K ﹤0.01% 2200
2023
Q1 		$55.7K Buy
6,062
+1,199
+25% +$12.9K ﹤0.01% 2254
2022
Q4 		$49.7K Sell
4,863
-214
-4% -$2.88K ﹤0.01% 2328
2022
Q3 		$74K Buy
5,077
+1,789
+54% +$23.2K ﹤0.01% 2193
2022
Q2 		$35K Sell
3,288
-17,186
-84% -$171K ﹤0.01% 2350
2022
Q1 		$220K Buy
20,474
+1,270
+7% +$17.1K ﹤0.01% 2541
2021
Q4 		$313K Buy
+19,204
New +$402K ﹤0.01% 2487

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allspring Global Investments's CTKB Position: Q4 2024 in Review

Allspring Global Investments sold out of Cytek Biosciences (CTKB) in Q4 2024, closing a stake of 929 shares — an estimated $5.15K sold.

Allspring Global Investments first reported a position in CTKB in Q4 2021 and held it in 10 quarters. The position peaked at $313K in Q4 2021. 152 funds tracked by Wall St. Rank hold CTKB as of Q4 2024.

  • Allspring Global Investments reported no remaining Cytek Biosciences position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 929 Cytek Biosciences shares in Q4 2024, an estimated $5.15K.
  • Allspring Global Investments first reported a position in Cytek Biosciences in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Cytek Biosciences position peaked at $313K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Cytek Biosciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.